Clinical Trials Logo

Clinical Trial Summary

Many people with symptomatic Osteoarthritis (OA) report chronic joint pain, especially if those patients are older than 50 years. In Europe OA is the most common form of chronic pain condition (34%) reported and entails a high economic and social burden for society. Probiotic treatment has been shown to promote bone metabolism, reduce pain and inflammatory responses of age-related musculoskeletal disorders, including OA. Gut microbiota has been proven to be of crucial importance in maintaining human health. However, the microbiota profile changes with aging, while the loss of microbiota diversity and the alterations in the optimal composition and quantity of beneficial microbes are believed to increase the risk of many diseases. Interestingly, emerging evidence leads to the hypothesis that alterations in the gut microbiome could also be considered as possible triggering factors in the onset of musculoskeletal disorders such as OA. We hypothesize that these patients with pain-OA will demonstrate an alteration of the gut microbiota to associated with the intensity of pain.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03968770
Study type Interventional
Source Fondazione Don Carlo Gnocchi Onlus
Contact Jorge H Villafañe, PhD
Phone +39 3395857563
Email mail@villafane.it
Status Not yet recruiting
Phase N/A
Start date June 1, 2019
Completion date July 2021

See also
  Status Clinical Trial Phase
Recruiting NCT02327650 - To Examine Whether or Not the Primary Causes of OA or RA Might be Bone Alterations
Recruiting NCT04238143 - Adipose-Derived Biocellular Regenerative Therapy for Osteoarthritis N/A
Not yet recruiting NCT03985709 - Probiotic for Osteoarthritis N/A
Recruiting NCT04192162 - Effects of Sulfur Water and Mud Therapy on Serotonin Activity and Biochemical Parameters in Patients' Osteoarthrosis N/A